期刊文献+

局部晚期宫颈癌术前新辅助化疗的应用价值 被引量:11

The Application Value of Preoperative Neoadjuvant Chemotherapy in the Treatment of Patients with Locally Advanced Cervical Cancer
暂未订购
导出
摘要 目的评价新辅助化疗对于局部晚期宫颈癌的术前疗效和手术效果。方法新辅助化疗组32例局部晚期宫颈癌术前进行2个周期的TP方案化疗,化疗结束后2~3周行广泛全子宫切除加盆腔淋巴结清扫术,并以同期相同条件的直接手术的32例局部晚期宫颈癌作为对照,观察化疗前后肿瘤大小、SCC值的变化和化疗毒副反应,并对两组手术情况和术后病理进行比较分析。结果新辅助化疗组患者化疗后肿瘤明显缩小(P〈0.05),其中3例达到CR,20例达到PR,总有效率为71.88%;SCC值也明显下降(P〈0.05);患者对化疗毒副反应均能耐受。与对照组相比,手术时间明显缩短,出血量明显减少,淋巴结阳性率、脉管受侵率及宫旁累及率显著降低(P〈0.05)。结论局部晚期宫颈癌术前新辅助化疗安全有效,有利于肿瘤切除,可提高患者生活质量。 Objective To investigate the preoperative and operative effects of neoadjuvant chemotherapy in the treatment of patients with locally advanced cervical cancer.Methods Two cycles of TP regimen chemotherapy were given to the 32 patients with locally advanced cervical cancer before the operation in the neoadjuvant chemotherapy group,then radical hysterectomy and pelvic lymphadenectomy were given for 2-3 weeks later.The other 32 patients with the same condition received primary surgery as the control group.The tumor size,the change of SCC and the chemotherapy toxicities were observed before and after chemotherapy,and the situation of operation and the postoperative pathology were compared between the two groups.Results The tumors were smaller significantly after chemotherapy in the neoadjuvant chemotherapy group(P〈0.05),among the 32 patients,the 3 cases got CR,the 20 cases got PR,the total response rate was 71.88%;SCC decreased significantly(P〈0.05);all the patients could tolerate the chemotherapy toxicities.Compared with the control group,the operation time was shortened significantly,the amount of bleeding was reduced significantly,the rate of lymph node metastasis,the invasion rate of intravascular and the involvement rate of parametrium decreased significantly in the neoadjuvant chemotherapy group(P〈0.05).Conclusion Preoperative neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer is safe and effective,it can do the benefit to the tumor resection,and improve the quality of life of the patients.
机构地区 启东市人民医院
出处 《肿瘤基础与临床》 2011年第5期397-399,共3页 journal of basic and clinical oncology
关键词 局部晚期宫颈癌 新辅助化疗 手术 locally advanced cervical cancer neoadjuvant chemotherapy operation
  • 相关文献

参考文献4

二级参考文献33

共引文献64

同被引文献96

  • 1徐虹,全培良,周云,王珍珍,蒋东霞.宫颈癌癌变过程中Caspase-3、Fas/FasL的表达及其临床意义[J].河南医学研究,2008,17(1):29-31. 被引量:6
  • 2宋水勤,张国楠.宫颈癌新辅助化疗现状[J].实用医院临床杂志,2005,2(2):22-25. 被引量:53
  • 3Plante M, Lau S, Brydon L, et al. Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage Ⅰ B1 cervical cancer: case report[J]. Gynecol Oncol,2006,101 (2) :367 - 370.
  • 4Marchiole P, Tigaud JD, Costantini S, et al. Neoadjuvant chemotherapy and vaginal radical trachelectomy for fertility-sparing treatment in women affected by cervical cancer ( FIGO stage Ⅰ B- Ⅱ A1 ) [ J ]. Gynecol Oncol,2011,122 ( 3 ) :484 - 490.
  • 5Kaneyasu Y, Nagai N, Nagata Y, et al. Intra-arterial intusion chemotherapy using cisplatin with radiotherapy for stage Ⅲ squamous cell carcinoma of the cervix [J]. Int J Radiat Oncol Biol Phys,2009,75 ( 2 ) : 369 - 377.
  • 6Chen H,Liang C ,Zhang L,et al. Clincial efficacy of modified preoperative neoauvant chemotherapy in the treatment of locally ad- vanced (stage Ⅰ b2 to ⅡB ) cervical cancer: randomized study [J]. Gyneeol Oncol,2008,110 ( 3 ) : 308 - 315.
  • 7Antonio GM, Lucia GC, Natalia C, et al. The current role of neoadjuvant chemotherapy in the management of cervical carcinoma [J]. Gynecol Oncol,2008,110 (3 Suppl 2) :36 - 40.
  • 8Blumenschein GR Jr, Kabbinavar F, Menon H, et al. A phase Ⅱ, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer[J]. Ann Oncol, 2011,22 (9) :2057 - 2067.
  • 9Miller K, Wang M, Gralow J, et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer[ J ]. N Engl J Med,2007,357 ( 26 ) : 2666 - 2676.
  • 10Kawase S, Okuda T, Ikeda M, et al. Intraarterial cisplatin/nedaplatin and ntravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer[ J ]. Gynecol Oncol,2006,102 ( 3 ) :493 - 499.

引证文献11

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部